[1]Vos LM,Morand PC,Biau D,et al.High frequency of polymicrobial infections after surgical resection of malignant bone and soft tissue tumors:A retrospective cohort study[J].Infectious Diseases and Therapy,2015,4(3):1-13.
[2]Zhang Hua,Zhou Wenbin,Borjigidai Almaz.The differential significance of procalcitonin and C-reactive protein in patients with fever of malignant tumor[J].Journal of Minzu University of China (Natural Science),2016,25(2):68-70.[张华,周文斌,阿里穆斯.降钙素原与C-反应蛋白在恶性肿瘤发热患者中的鉴别意义[J].中央民族大学学报(自然科学版),2016,25(2):68-70.]
[3]Chu NJ,Armstrong TD,Jaffee EM.Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention[J].Clinical Cancer Research,2015,21(7):1549-1557.
[4]Liu Pingping,Zheng Li,Zhang Hao,et al.The early diagnostic value of PCT and C-reactive protein in malignant tumor complicated with infection[J].Zhejiang Clinical Medicine,2014,15(9):1383-1384.[刘平平,郑力,张浩,等.PCT和C-反应蛋白在恶性肿瘤合并感染的早期诊断价值[J].浙江临床医学,2014,15(9):1383-1384.]
[5]He Guoqiang,Zhang Heping,Dang Yuanna.Evaluation of serum procalcitonin in the diagnosis of infection in patients with malignant tumors[J].Chin J Nosocomiol,2015,25(14):3135-3137.[何国强,张和平,党元娜.血清降钙素原检测在恶性肿瘤患者感染诊断中的应用评价[J].中华医院感染学杂志,2015,25(14):3135-3137.]
[6]Xu Liwen,Zhang Qin,Hu Ming,et al.Investigation of infection in patients with malignant tumors and analysis of related factors[J].Chin J Nosocomiol,2016,26(11):2526-2528.[许琍文,张芹,胡明,等.恶性肿瘤患者感染调查及相关因素分析[J].中华医院感染学杂志,2016,26(11):2526-2528.]
[7]Jiang Zhengcai,Zhu Shaojun,Dong Jianda,et al.Influencing factors of nosocomial infection in patients with malignant tumors[J].Chin J Nosocomiol,2016,26(8):1781-1783.[蒋正财,朱少俊,董剑达,等.恶性肿瘤患者医院感染影响因素分析研究[J].中华医院感染学杂志,2016,26(8):1781-1783.]
[8]Liu Ronghua,Guan Li,Zhang Yaqing,et al.Risk factors of invasive fungal infections in malignant tumor patients[J].Modern Oncology,2015,23(22):3344-3346.[刘荣华,关丽,张亚庆,等.恶性肿瘤患者侵袭性真菌感染危险因素分析[J].现代肿瘤医学,2015,23(22):3344-3346.]
[9]Hu Haoyun,Zhou Lei,Gao Xiang,et al.The value of C reactive protein in the diagnosis and monitoring of infection in patients with tumor[J].Laboratory Medicine,2016,31(4):253-257.[胡昊昀,周磊,高翔,等.C 反应蛋白在肿瘤患者感染的诊断和病情监测中的价值[J].检验医学,2016,31(4):253-257.]
[10]Wei Yuanyuan,Hu Yijiang,Gu Yongkun.Effectiveness of determination of levels of serum procalcitonin and C-reactive protein in diagnosis of infections in malignant tumor patients[J].Chin J Nosocomiol,2015,25(1):16-18.
[11]Da Chunli,Yang Feng,Li Yu.Clinical significance of procalcitonin and APACHEⅡfor catheter related bloodstream infection in tumor patients[J].Xinjiang Medical Journal,2012,42(3):13-16.[达春丽,杨峰,李瑜.降钙素原和APACHEⅡ评分在恶性肿瘤患者导管相关性血行感染诊疗中的临床意义[J].新疆医学,2012,42(3):13-16.]
[12]Liu Rong.Evaluation of serum procalcitonin and C-reactive protein levels in the detection of infectious diseases in patients with malignant tumors[J].Aerospace Medicine,2016,27(1):40-41.[刘荣.血清降钙素原与C-反应蛋白水平在检测恶性肿瘤患者感染性疾病中的应用评价[J].航空航天医学杂志,2016,27(1):40-41.]
[13]Hao Jingduo,Cen Xueying,Ge Zuyin.Value of joint detection of serum procalcitonin and C-reactive protein in monitoring of infections in malignant tumor patients[J].Chin J Nosocomiol,2015,25(2):268-270.
[14]Zhang Jingya,Cui Ranliang,Wei Qian,et al.The diagnostic value of procalcitonin in postoperative infection of ICU malignant tumor[J].Chinese Journal of General Surgery,2016,31(8):689-690.[张静雅,崔冉亮,魏倩,等.降钙素原在ICU恶性肿瘤患者术后感染中的诊断价值[J].中华普通外科杂志,2016,31(8):689-690.]
[15]Li Yanwei,Li Ronghui,Ju Chuanyu,et al.The clinical value of combined detection of PCT,CRP and WBC in patients with malignant tumor after radiotherapy and chemotherapy[J].Journal of Clinical Medical Literature(Electronic Edition),2017,4(10):178-180.[李彦伟,李荣辉,鞠传余,等.恶性肿瘤放化疗后感染患者PCT、CRP及WBC联合检测的应用价值[J].临床医药文献电子杂志,2017,4(10):178-180.]
[16]Wang Shufeng,Du Ping,Yao Xiaobin.Changes and significance of procalcitonin and C reactive protein levels in patients with malignant tumor and bacterial infection[J].Chinese Journal of Practical Diagnosis and Therapy,2015,29(5):517-518.[王书锋,杜平,姚晓斌.恶性肿瘤并细菌感染患者降钙素原与C反应蛋白水平变化及意义[J].中华实用诊断与治疗杂志,2015,29(5):517-518.]